A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder
Adderall Outperforms Methylphenidate (Ritalin) for Full-Day ADHD Symptom Control
Pelham WE, Gnagy EM, Chronis AM, Burrows-MacLean L, Fabiano GA, Onyango AN, Meichenbaum DL, Williams A, Aronoff HR, Steiner RL
journal
Pediatrics
Date Published
1999 Dec
Why link to a visual abstract?
What is a visual abstract?
Visual
Original
Study Summary
π¬
What They Studied
The study aimed to compare the effects of different dosing schedules of methylphenidate and Adderall on children with ADHD during a school day, and to evaluate late-afternoon doses on evening behavior and side effects.
π‘
What They Found
A single morning dose of Adderall provided comparable behavioral effects throughout a school day as twice-daily methylphenidate, while afternoon doses of Adderall and methylphenidate affected evening behavior differently.
π
What This Means
These findings show Adderall can be used as a long-acting stimulant similar to twice-daily methylphenidate based on its all-day effectiveness, aligning with Adderall's role in enhancing attention in ADHD treatment plans as indicated in currentEvidence.
Study Summary
Study Overview
The study aimed to understand how different medications affect children's behavior and performance throughout the school day. Researchers looked at two common drugs, Adderall and methylphenidate (MPH), to see how they work over time. They found that both medications improved children's behavior significantly during a typical school day.
However, the way these medications were given, especially the timing of doses, played a vital role in effectiveness.
The results show that a single morning dose of Adderall can provide benefits similar to taking MPH twice a day. This suggests that children who struggle with midday doses could find better solutions with single doses in the morning, especially when combined with behavioral training. The findings spark ideas for future studies to explore the best dosing strategies for children using these medications.
Abstract: background
1) To compare standard twice-daily methylphenidate (MPH) dosing with a single morning dose of MPH and of Adderall during a typical school-day time period, and 2) to conduct a dose-response study of the effects of a late-afternoon (3:30 PM) dose of MP...more
Effectiveness of Morning Doses
"In summary, the current results show that, at least in the context of an intensive behavioral intervention, a single morning dose of Adderall had behavioral effects throughout a time period similar to an entire school day that were equivalent to standard twice-daily MPH dosing."
Potential Benefits of Dosing Strategy
"Our findings suggest that evening side effects may make single daily dosing (or at least no dosing after noontime) the preferred dosing strategy for most children when parent training is provided."
Role of Behavioral Intervention
"It is possible that the concurrent behavioral intervention in our STP interacted with medication such that positive behavioral changes in the morning carried through the remainder of the day."
Study Summary
Methods
The study employed a within-subject, placebo-controlled, crossover design, conducted within a structured summer program rich with behavioral strategies. It involved 21 children aged 6 to 12 with ADHD, of whom the majority were boys. Participants were given different treatments in a random order, switching daily between conditions such as placebo, varying doses of Ritalin, and Adderall.
The focus was on observing their behavior from morning until late afternoon and assessing the effectiveness of the medication at different times of the day. The goal was to see how the medications impacted social and academic behaviors by collecting ratings from both counselors and teachers. Parents also provided their observations on children's evening behavior and any side effects after the 3:30 PM dosing.
Abstract: methods
Design: Within-subject, placebo-controlled, crossover design. Setting: Intensive summer treatment program with a comprehensive behavioral approach. Study participants: Twenty-one children with attention-deficit/hyperactivity disorder (19 boys and 2 g...more
Study Summary
Results
The findings revealed that a single morning dose of Adderall was as effective as twice-daily doses of Ritalin in controlling behavior throughout the school day. Meanwhile, one morning dose of Ritalin was found to be less effective, losing its impact by early to mid-afternoon. Some children did maintain good behavior with just one dose of Ritalin within this program setting.
In terms of evening behavior, a 0.3 mg/kg dose of Ritalin at 3:30 PM was more effective than a smaller dose, while no significant difference was found between the low and high doses of Adderall. Notably, Adderall showed positive effects on evening conduct across all dosing schedules, even when only a morning dose was provided.
Abstract: results
A single morning dose of Adderall produced equivalent behavioral effects to those of MPH received twice-daily and behavioral effects of that single morning dose lasted throughout the school-day period. One morning dose of MPH was less effective than ...more
Study Summary
Conclusions
The study concluded that in the intensive behavioral context, Adderall taken as a single morning dose effectively maintained behavioral control through the typical school day, matching the efficacy of the standard twice-daily Ritalin regime. This suggests that Adderall might be a suitable option for children who face challenges with taking medication during school hours due to its long-lasting effects.
The study suggests the need for future research, particularly dose-response comparisons in standard school settings, and further examination of Adderall in comparison to Ritalin and similar medications. Such research could offer deeper insights into the timing and benefits of using Adderall in managing ADHD.
Abstract: conclusions
The results show that, at least in the context of an intensive behavioral intervention, a single morning dose of Adderall had behavioral effects throughout an entire school day period that were equivalent to standard twice-daily MPH dosing. These res...more
Background Information
Patient Guide
π
Adderall as ADHD Treatment
FDA approves Adderall for ADHD in children, enhancing attention and reducing impulsivity.
π
Methylphenidate Formulations
Available in multiple forms, methylphenidate offers flexible dosing options for ADHD management.
β°
Dosing and Administration
Adderall and methylphenidate are typically taken in the morning, with doses spaced throughout the day.
π
Potential Side Effects
Both medications can affect growth and have cardiovascular and psychiatric risks in children.
π
Monitoring Requirements
Monitoring for side effects and signs of misuse is important in ADHD pharmacotherapy.
Professional Guide
Expert Opinion: Adderall Outperforms Methylphenidate (Ritalin) for Full-Day ADHD Symptom Control
In line with the study, professional guidelines highlight the role of methylphenidate as the recommended first-line treatment for young children, underscoring its established efficacy.
Attention must be given to the cardiovascular side effects associated with stimulant medications, as mild increases in heart rate and blood pressure are common, though monitoring is advised for significant changes in some individuals.
While methylphenidate effectively increases norepinephrine and dopamine concentrations, the response between individuals to methylphenidate versus amphetamine remains unpredictable, with no clear predictors identified.
Combining behavioral therapy with stimulant medication has shown benefits in some cases beyond medication alone, particularly in addressing parental and teacher concerns.
Considering the potential for adverse effects like growth suppression and the exacerbation of psychotic symptoms, the strategic use of stimulants must be carefully managed.
Psychosocial interventions that integrate efforts across school and home settings further enhance treatment outcomes, emphasizing a holistic approach.
Evidence Summary
Concerta vs. MPH: Daily Dosing Debated
Concerta simplifies ADHD treatment with a once-a-day regimen compared to the multiple doses required with methylphenidate (MPH). This makes it easier to manage in a busy day. Both medications support ADHD management but require different routines.
The study below looks into how doses impact behavior, but here the focus stays on weighing Concerta's convenience against MPH's frequent dosing.
Evidence Summary
Evaluating ADHD Treatments: Medications vs. Therapies
The review focuses on assessing how effective different treatments are for children with ADHD, examining both medication and behavioral therapies. By analyzing various studies, the research draws broad conclusions on their impact and effectiveness. The article highlights the comparison of these treatments to determine their overall efficiency for managing symptoms.
Evidence Summary
Understanding ADHD Medication's Impact on Learning
ADHD can significantly disrupt children's behavior and performance at school. While medication can help, the precise impact on learning isn't fully understood. A comprehensive review analyzed various medications, showing mixed results on academic tasks like arithmetic. However, children consistently spent more time focused and completed up to 15% more school work.
The findings indicate these drugs positively influence students' educational experiences, as highlighted in the detailed study.
Evidence Summary
Cardiac Safety in ADHD Medications: An In-depth Look
Adderall and methylphenidate are central nervous system stimulants used for ADHD, but concerns about their cardiac safety persist. Researchers examined the cardiac risk in almost 2.1 million children and adolescents using data from Florida Medicaid. They tracked emergency room visits for heart issues, comparing current and former users of methylphenidate and amphetamine salts.
Results revealed no significant difference in cardiac risk between current users of either stimulant type, highlighting potential safety in terms of heart-related effects. Similarly, for previous users, no heightened cardiac risk was associated with past exposure to either medication.